BTIG Research has recently initiated Douglas Elliman Inc (DOUG) stock to Neutral rating, as announced on July 18, 2023, according to Finviz. Analyst ratings are significant because they provide ...

BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...

Aclaris (ACRS) soared 60% Tuesday, the day after the company announced it was licensing two drug candidates, prompting ...

BTIG Research began coverage on shares of VYNE Therapeutics (NASDAQ:VYNE – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat.com reports. The brokerage set a ...

On Tuesday, Lyra Therapeutics Inc (LYRA) stock saw a modest uptick, ending the day at $0.2 which represents a slight increase of $0.03 or 17.65% from the prior close of $0.17. The stock opened at ...

Donald Trump has been somewhat cagey about his economic plans — especially tariffs — since voters elected him president. That ...

Donald Trump has been somewhat cagey about his economic plans — especially tariffs — since voters elected him president. That ...

“Donald Trump cares about independent validators. And the biggest independent validator of his success is the market. It’s a ...

Natural Alternatives International Inc (NAII) is expected to report for 1Q. New Concept Energy Inc (GBR) is expected to report for 3Q. Nuvei Corp (NVEI.T) is expected to report $0.17 for 3Q. Phio ...

Simulations Plus, Inc. ("Simulations Plus"), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, ...

BSI-045B is also being advanced in multiple Phase 2 studies in China by Biosion’s regional partner, Chia Tai Tianqing ...

CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Get Free Report) shares shot up 1.6% during trading on Monday after Truist Financial raised their price target on the stock from $325.00 to $375.00. Truist ...